(Q24186538)

title

Amitriptyline for neuropathic pain in adults (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6447238&resulttype=core&format=json

13 May 2020

0 references

1 reference

5

Philip J Wiffen

Philip J

Wiffen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6447238&resulttype=core&format=json

13 May 2020

3

Dominic Aldington

Dominic

Aldington

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6447238&resulttype=core&format=json

13 May 2020

2

Sheena Derry

Sheena

Derry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6447238&resulttype=core&format=json

13 May 2020

1

R Andrew Moore

R Andrew

Moore

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6447238&resulttype=core&format=json

13 May 2020

Peter Cole

4

Peter

Cole

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6447238&resulttype=core&format=json

Cochrane Database of Systematic Reviews

13 May 2020

publication date

6 July 2015

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6447238&resulttype=core&format=json

13 May 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6447238&resulttype=core&format=json

13 May 2020

page(s)

CD008242

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6447238&resulttype=core&format=json

Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life

13 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Blinding effectiveness and association of pretreatment expectations with pain improvement in a double-blind randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Randomized double-blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Central post-stroke pain--a controlled trial of amitriptyline and carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Amitriptyline, but not lorazepam, relieves postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Treatment response in antidepressant-naïve postherpetic neuralgia patients: double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Comparative study of clinical efficacy with amitriptyline, pregabalin, and amitriptyline plus pregabalin combination in postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

A comparative study of efficacy and safety of gabapentin versus amitriptyline as coanalgesics in patients receiving opioid analgesics for neuropathic pain in malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Amitriptyline vs. pregabalin in painful diabetic neuropathy: a randomized double blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Clomipramine and Amitriptyline in the Treatment of Severe Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

A comparative evaluation of amitriptyline and duloxetine in painful diabetic neuropathy: a randomized, double-blind, cross-over clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Amitriptyline in the prophylaxis of central poststroke pain. Preliminary results of 39 patients in a placebo-controlled, long-term study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Low dose amitriptyline in the treatment of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Dose-response for analgesic effect of amitriptyline in chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Trial of amitriptyline for relief of pain in amputees: results of a randomized controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Depression masquerading as diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Effect of minocycline on lumbar radicular neuropathic pain: a randomized, placebo-controlled, double-blind clinical trial with amitriptyline as a comparator

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Antidepressants for cancer pain and other painful syndromes with deafferentation component: comparison of amitriptyline and trazodone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Amitriptyline versus placebo in postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Postamputation pain and sensory changes in treatment-naive patients: characteristics and responses to treatment with tramadol, amitriptyline, and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Low dose amitriptyline in chronic pain: the gain is modest

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Prevalence of chronic pain with neuropathic characteristics in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitati

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Influence of trial sample size on treatment effect estimates: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Topical capsaicin (low concentration) for chronic neuropathic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Topical capsaicin (high concentration) for chronic neuropathic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Topical lidocaine for neuropathic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Algorithm for neuropathic pain treatment: an evidence based proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

An observational descriptive study of the epidemiology and treatment of neuropathic pain in a UK general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Analgesic therapy in postherpetic neuralgia: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Drugs for neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Epidemiology and Clinical Features of Idiopathic Trigeminal Neuralgia and Glossopharyngeal Neuralgia: Similarities and Differences, Rochester, Minnesota, 1945-1984

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Incidence of facial pain in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Meta-analysis in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Brain imaging of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Pregabalin for acute and chronic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

"Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen/paracetamol combinations after third molar extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Expect analgesic failure; pursue analgesic success

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Gabapentin for chronic neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Duloxetine use in chronic painful conditions--individual patient data responder analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Amitriptyline for fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Treatment of neuropathic pain: an overview of recent guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Neuropathic features of joint pain: a community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Pregabalin in fibromyalgia--responder analysis from individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

The Epidemiology of Chronic Pain of Predominantly Neuropathic Origin. Results From a General Population Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Can neuroimaging studies identify pain endophenotypes in humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Neuropathic pain: redefinition and a grading system for clinical and research purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Neuropathic pain in the general population: a systematic review of epidemiological studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Non-steroidal anti-inflammatory drugs for neuropathic pain: how do we explain continued widespread use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Deconstructing the neuropathic pain phenotype to reveal neural mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Lamotrigine for chronic neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Effects of treatments for symptoms of painful diabetic neuropathy: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

A systematic review of antidepressants in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Amitriptyline for neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

Antidepressants for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

A new definition of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008242.PUB3

A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy.

21 January 2018

1 reference

12 December 2020

Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study.

1 reference

12 December 2020

[Comparison of efficacy of gabapentin and amitriptyline in the management of peripheral neuropathic pain]

1 reference

12 December 2020

Pregabalin for acute and chronic pain in adults

1 reference

12 December 2020

Amitriptyline in the prevention of chemotherapy-induced neuropathic symptoms.

1 reference

12 December 2020

A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: a prospective randomized double-blind placebo-controlled study

1 reference

12 December 2020

Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses

1 reference

12 December 2020

Chronic pain: genes, plasticity, and phenotypes

1 reference

12 December 2020

A controlled study of psychotherapy and amitriptyline used individually and in combination in the treatment of chronic intractable, 'psychogenic' pain

1 reference

12 December 2020

Distigmine and amitriptyline in the treatment of chronic pain.

1 reference

12 December 2020

Trazodone for deafferentation pain. Comparison with amitriptyline.

1 reference

12 December 2020

The analgesic effect of amitriptyline on chronic facial pain

1 reference

12 December 2020

A trial of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathy

1 reference

12 December 2020

A controlled study of amitriptyline in the treatment of chronic pain

1 reference

12 December 2020

Developing a database of published reports of randomised clinical trials in pain research

1 reference

12 December 2020

10.1002/14651858.CD008242.PUB3

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

538487

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6447238&resulttype=core&format=json

release_osjuoxeapraibgh4hthob4ezfu

13 May 2020

Fatcat ID

0 references

538487

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6447238&resulttype=core&format=json

13 May 2020

PubMed publication ID

26146793

2 references

Consolidated OpenCitations Corpus – April 2017

538487